Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Solmi

Showing results (81-90 of 580) with videos related to

Pageof 58
Sort By:
Psychosomatic Medicine|October 28, 2017
Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-AnalysisNicola Veronese, Brendon Stubbs, Marco Solmi, et al.
Schizophrenia Bulletin|November 5, 2022
Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in FinlandMarco Solmi, Markku Lähteenvuo, Christoph U Correll, et al.
Epidemiology and Psychiatric Sciences|March 9, 2019
Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis - CORRIGENDUMMarco Solmi, Ai Koyanagi, Trevor Thompson, et al.
Psychiatry and Clinical Neurosciences|September 30, 2021
Secondary Mania induced by TNF-α inhibitors: A systematic reviewAlessandro Miola, Veronica Dal Porto, Nicola Meda, et al.
Journal of Psychiatry & Neuroscience : JPN|July 3, 2025
Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophreniaNicholas Fabiano, Carl Zhou, Stanley Wong, et al.
Journal of Affective Disorders|January 25, 2016
A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblingsLeonardo Zaninotto, Marco Solmi, Tommaso Toffanin, et al.
Experimental Gerontology|June 6, 2016
Is pain sensitivity altered in people with Alzheimer's disease? A systematic review and meta-analysis of experimental pain researchBrendon Stubbs, Trevor Thompson, Marco Solmi, et al.
Neurology|March 8, 2019
NMDA receptor antagonists and pain relief: A meta-analysis of experimental trialsTrevor Thompson, Fiona Whiter, Katy Gallop, et al.
International Journal of Geriatric Psychiatry|May 9, 2020
Relationship between multidimensional prognostic index and incident depressive symptoms in older people: Findings from the Irish Longitudinal Study on AgeingNicola Veronese, Ai Koyanagi, Lee Smith, et al.
Psychology Research and Behavior Management|January 11, 2024
Distress Symptoms of Old Age and Mild Cognitive Impairment are Two Distinct Dimensions in Older Adults Without Major DepressionVinh-Long Tran-Chi, Michael Maes, Gallayaporn Nantachai, et al.
Pageof 58

Showing results (81-90 of 580) with videos related to

Sort By:
Pageof 58
Psychosomatic Medicine|October 28, 2017
Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-AnalysisNicola Veronese, Brendon Stubbs, Marco Solmi, et al.
Schizophrenia Bulletin|November 5, 2022
Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in FinlandMarco Solmi, Markku Lähteenvuo, Christoph U Correll, et al.
Epidemiology and Psychiatric Sciences|March 9, 2019
Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis - CORRIGENDUMMarco Solmi, Ai Koyanagi, Trevor Thompson, et al.
Psychiatry and Clinical Neurosciences|September 30, 2021
Secondary Mania induced by TNF-α inhibitors: A systematic reviewAlessandro Miola, Veronica Dal Porto, Nicola Meda, et al.
Journal of Psychiatry & Neuroscience : JPN|July 3, 2025
Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophreniaNicholas Fabiano, Carl Zhou, Stanley Wong, et al.
Journal of Affective Disorders|January 25, 2016
A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblingsLeonardo Zaninotto, Marco Solmi, Tommaso Toffanin, et al.
Experimental Gerontology|June 6, 2016
Is pain sensitivity altered in people with Alzheimer's disease? A systematic review and meta-analysis of experimental pain researchBrendon Stubbs, Trevor Thompson, Marco Solmi, et al.
Neurology|March 8, 2019
NMDA receptor antagonists and pain relief: A meta-analysis of experimental trialsTrevor Thompson, Fiona Whiter, Katy Gallop, et al.
International Journal of Geriatric Psychiatry|May 9, 2020
Relationship between multidimensional prognostic index and incident depressive symptoms in older people: Findings from the Irish Longitudinal Study on AgeingNicola Veronese, Ai Koyanagi, Lee Smith, et al.
Psychology Research and Behavior Management|January 11, 2024
Distress Symptoms of Old Age and Mild Cognitive Impairment are Two Distinct Dimensions in Older Adults Without Major DepressionVinh-Long Tran-Chi, Michael Maes, Gallayaporn Nantachai, et al.
Pageof 58